BID

BID

Target · BH3-only apoptosis regulator

BID BH3 interacting domain death agonist

BID (BH3 interacting domain death agonist) is a pro-apoptotic member of the BCL-2 family of cell death regulators. It induces ICE-like proteases and apoptosis, and links caspase-8 activity to mitochondrial damage. Browse Assay Genie's current range of BID research reagents below, or read on for the biology behind the target.

Mitochondrial outer membraneBH3-only death agonistCleaved by caspase-8
195 aa
Protein length
~22 kDa
Molecular weight
22q11.21
Gene locus
BH3-only
Protein family
Target information

What is BID (BH3 interacting domain death agonist)?

BID is a death agonist that induces ICE-like proteases and apoptosis. It belongs to the BCL-2 family of cell death regulators and heterodimerises with either the agonist BAX or the antagonist BCL2, and in this way helps to regulate apoptosis. HGNC places it in the BCL2 homology region 3 (BH3) only group.

BID is a mediator of mitochondrial damage induced by caspase-8 (CASP8). CASP8 cleaves the BID protein, and the COOH-terminal part then translocates to mitochondria, where it triggers cytochrome c release. This cleavage step connects upstream caspase signalling to the mitochondrial arm of apoptosis, which makes BID a useful readout when studying how cell death signals are passed between these compartments. UniProt records the protein in the cytoplasm and at the mitochondrion membrane, including the outer membrane.

The human BID gene is also classed by HGNC among receptor ligands and among microRNA protein coding host genes. Multiple alternatively spliced transcript variants have been found, so researchers working with BID antibody or BID ELISA kit reagents should consider which forms they wish to detect. Mouse and rat each have a Bid ortholog, allowing the same pathway to be studied in common model systems.

Apoptosis signalling

BID induces ICE-like proteases and apoptosis, making it a central protein for studying how cell death is initiated and regulated.

Caspase-8 cleavage studies

CASP8 cleaves BID, and its COOH-terminal part moves to mitochondria, so BID is used to follow caspase-8-driven death signals.

Mitochondrial cytochrome c release

The cleaved BID fragment triggers cytochrome c release from mitochondria, a key step in mitochondrial damage and apoptosis.

BCL-2 family interactions

BID heterodimerises with BAX or BCL2, offering a model for how BH3-only proteins balance pro- and anti-apoptotic activity.

Background

BID frequently asked questions

What does BID do?

BID is a death agonist of the BCL-2 family that induces ICE-like proteases and apoptosis. It heterodimerises with BAX or BCL2 to regulate apoptosis, and after caspase-8 cleavage its COOH-terminal part moves to mitochondria and triggers cytochrome c release.

Does BID have isoforms or alternative names?

The approved name is BH3 interacting domain death agonist, and UniProt uses BH3-interacting domain death agonist. No other aliases or previous symbols are listed. NCBI Gene reports multiple alternatively spliced transcript variants for the BID gene.

Is BID conserved in mouse and rat?

Yes. Mouse and rat both carry a Bid ortholog, so the protein can be studied in common rodent models. Check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.

Explore

Related targets

Other BCL-2 family members, caspases and mitochondrial apoptosis markers that work alongside BID.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P55957; product specifications from Assay Genie datasheets.

BID Product listing